{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:00:50Z","timestamp":1793948450991,"version":"4.8.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00467-022-05838-1","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T15:46:49Z","timestamp":1673365609000},"page":"3947-3954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The first randomized controlled trial in pediatric nephrology: the history of the International Study of Kidney Disease in Children (ISKDC)"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1240-8161","authenticated-orcid":false,"given":"William A.","family":"Primack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin V.","family":"Lemley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria F.","family":"Norwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Silverstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Kaskel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"5838_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/978-3-642-69863-7_5","volume-title":"Pediatric Nephrology","author":"H Barnett","year":"1984","unstructured":"Barnett H (1984) Philosophy and ethics of multicenter international controlled clinical trials in children. In: Brodehl J, Ehrich JHH (eds) Pediatric Nephrology. Springer Verlag, Berlin, pp 30\u201335"},{"key":"5838_CR2","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/s0022-3476(77)80619-7","volume":"90","author":"CD West","year":"1977","unstructured":"West CD (1977) Anticoagulant and immunosuppressive drugs in the treatment of severe glomerulonephritis with coagulopathy. J Pediatr 90:1051\u20131052. https:\/\/doi.org\/10.1016\/s0022-3476(77)80619-7","journal-title":"J Pediatr"},{"key":"5838_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/s0031-3955(16)32555-x","volume":"18","author":"GC Arneil","year":"1971","unstructured":"Arneil GC (1971) An international cooperative study, societies of paediatric nephrology, and Henry L Barnett. Pediatr Clin North Am 18:349\u2013354. https:\/\/doi.org\/10.1016\/s0031-3955(16)32555-x","journal-title":"Pediatr Clin North Am"},{"key":"5838_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJM197902013000511","volume":"300","author":"International Study of Kidney Disease in Children","year":"1979","unstructured":"International Study of Kidney Disease in Children (1979) International trials and pediatric nephrology. N Engl J Med 300:254\u2013255. https:\/\/doi.org\/10.1056\/NEJM197902013000511","journal-title":"N Engl J Med"},{"key":"5838_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3181\/00379727-74-17809","volume":"74","author":"EB Farnsworth","year":"1950","unstructured":"Farnsworth EB (1950) Metabolic changes associated with administration of adrenocorticotropin in the nephrotic syndrome. Proc Soc Exp Biol Med 74:60\u201362. https:\/\/doi.org\/10.3181\/00379727-74-17809","journal-title":"Proc Soc Exp Biol Med"},{"key":"5838_CR6","first-page":"519","volume":"80","author":"HL Barnett","year":"1950","unstructured":"Barnett HL, McNamara H, McCrory W, Forman C, Rapoport M, Michie A, Barbero G (1950) The effects of ACTH and cortisone on the nephrotic syndrome. AMA Am J Dis Child 80:519\u2013520","journal-title":"AMA Am J Dis Child"},{"key":"5838_CR7","doi-asserted-by":"publisher","unstructured":"Luetscher JA Jr, Deming QB, JohnsonBB HJ, Lew W, Poo LJ (1951) Treatment of nephrosis with pituitary adrenocorticotrophin. J Clin Invest 30:1530\u20131541. https:\/\/doi.org\/10.1172\/JCI10256","DOI":"10.1172\/JCI10256"},{"key":"5838_CR8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/s0140-6736(61)91026-1","volume":"2","author":"GC Arneil","year":"1961","unstructured":"Arneil GC (1961) 164 children with nephrosis. Lancet 2:1103\u20131110. https:\/\/doi.org\/10.1016\/s0140-6736(61)91026-1","journal-title":"Lancet"},{"key":"5838_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/archpedi.1960.04020040375010","volume":"100","author":"JL Kohn","year":"1960","unstructured":"Kohn JL, Gribetz D (1960) Nephrotic syndrome of childhood. Comparison of results of current hormonal therapy with those achieved previously. Am J Dis Child 100:373\u2013376","journal-title":"Am J Dis Child"},{"key":"5838_CR10","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1542\/peds.5.3.486","volume":"5","author":"L Barness","year":"1950","unstructured":"Barness L, Moll G, Janeway C (1950) Nephrotic syndrome: natural history of the disease. Pediatrics 5:486\u2013503. https:\/\/doi.org\/10.1542\/peds.5.3.486","journal-title":"Pediatrics"},{"key":"5838_CR11","doi-asserted-by":"publisher","unstructured":"(1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159\u2013165. https:\/\/doi.org\/10.1038\/ki.1978.23","DOI":"10.1038\/ki.1978.23"},{"key":"5838_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, Cook HT, Fervenza FC, Gibson KL, Glassock RJ, Jayne DRW, Jha V, Liew A, Liu ZH, Mej\u00eda- Vilet JM, Nester CM, Radhakrishnan J, Rave EM, Reich HN, Ronco P, Sanders JF, Sethi S, Suzuki Y, Tang SCW, Tesar V, Vivarelli M, Wetzels JFM, Lytvyn L, Craig JC, Tunnicliffe DJ, Howell M, Tonelli MA, Cheung M, Earley A, Floege J (2021) Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. Kidney Int 100:753\u2013779. https:\/\/doi.org\/10.1016\/j.kint.2021.05.015","journal-title":"Kidney Int"},{"key":"5838_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1056\/NEJM196704132761501","volume":"276","author":"AF Michael","year":"1967","unstructured":"Michael AF, Vernier RL, Drummond KN, Levitt JI, Herdman RC, Fish AJ, Good RA (1967) Immunosuppressive therapy of chronic renal disease. N Engl J Med 276:817\u2013828. https:\/\/doi.org\/10.1056\/NEJM196704132761501","journal-title":"N Engl J Med"},{"key":"5838_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1001\/archpedi.1958.02060050502007","volume":"95","author":"CD West","year":"1958","unstructured":"West CD (1958) Use of combined hormone and mechlorethamine (nitrogen mustard) therapy in lipoid nephrosis. AMA J Dis Child 95:498\u2013515. https:\/\/doi.org\/10.1001\/archpedi.1958.02060050502007","journal-title":"AMA J Dis Child"},{"key":"5838_CR15","first-page":"524","volume":"98","author":"KN Drummond","year":"1968","unstructured":"Drummond KN, Hillman DA, Marchessault JH, Feldman W (1968) Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings. Can Med Assoc J 98:524\u2013531","journal-title":"Can Med Assoc J"},{"key":"5838_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/s0140-6736(70)90108-x","volume":"2","author":"TM Barratt","year":"1970","unstructured":"Barratt TM, Soothill JF (1970) Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet 2:479\u2013482. https:\/\/doi.org\/10.1016\/s0140-6736(70)90108-x","journal-title":"Lancet"},{"key":"5838_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1001\/jama.1967.03120070071009","volume":"199","author":"DA Adams","year":"1967","unstructured":"Adams DA, Gordon A, Maxwell MH (1967) Azathioprine treatment of immunological renal disease. JAMA 199:459\u2013463","journal-title":"JAMA"},{"key":"5838_CR18","first-page":"1141","volume":"21","author":"HL Barnett","year":"1979","unstructured":"Barnett HL (1979) International study of kidney disease in children. Nihon Jinzo Gakkai Shi 21:1141\u20131144","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"5838_CR19","unstructured":"Spitzer A (1977) Ten years of activity: A report for the International Study of kidney Disease in Children. In: Kluthe R, Vogt A, Botsford (eds) Glomerulonephritis. Wiley, New York, pp 201\u2013210"},{"key":"5838_CR20","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/s0140-6736(70)91093-7","volume":"1","author":"M Abramowicz","year":"1970","unstructured":"Abramowicz M, Barnett HL, Edelmann CM Jr, Greifer I, Kobayashi O, Arneil GC, Barron BA, Gordillo-P G, Hallman N, Tiddens HA (1970) Controlled trial of azathioprine in children with nephrotic syndrome: a report for the international study of kidney disease in children. Lancet 1:959\u2013961. https:\/\/doi.org\/10.1016\/s0140-6736(70)91093-7","journal-title":"Lancet"},{"key":"5838_CR21","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/s0140-6736(70)91905-7","volume":"760","author":"J Churg","year":"1970","unstructured":"Churg J, Habib R, White RH (1970) Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet 760:1299\u20131302. https:\/\/doi.org\/10.1016\/s0140-6736(70)91905-7","journal-title":"Lancet"},{"key":"5838_CR22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1172\/JCI105555","volume":"46","author":"CD West","year":"1967","unstructured":"West CD, Winter S, Forristal J, McConville JM, Davis NC (1967) Evidence for in vivo breakdown of beta-10-globulin in hypocomplementemic glomerulonephritis. J Clin Invest 46:539\u2013548. https:\/\/doi.org\/10.1172\/JCI105555","journal-title":"J Clin Invest"},{"key":"5838_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF00866289","volume":"6","author":"P Tarshish","year":"1992","unstructured":"Tarshish P, Bernstein J, Tobin JN, Edelmann CM Jr (1992) Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone\u2013a report of the International Study of Kidney Disease in Children. Pediatr Nephrol 6:123\u2013130. https:\/\/doi.org\/10.1007\/BF00866289","journal-title":"Pediatr Nephrol"},{"key":"5838_CR24","unstructured":"(1974) Prospective controlled trial of cyclophosphamide therapy in children with nephrotic syndrome Report of the International Study of Kidney Disease in Children. Lancet 2:423\u2013427"},{"key":"5838_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0140-6736(75)91068-5","volume":"1","author":"TM Barratt","year":"1975","unstructured":"Barratt TM, Bercowsky A, Osofsky SG, Soothill JF (1975) Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood. Lancet 1:55\u201358. https:\/\/doi.org\/10.1016\/s0140-6736(75)91068-5","journal-title":"Lancet"},{"key":"5838_CR26","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s004670050167","volume":"10","author":"P Tarshish","year":"1996","unstructured":"Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1996) Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. Pediatr Nephrol 10:590\u2013593. https:\/\/doi.org\/10.1007\/s004670050167","journal-title":"Pediatr Nephrol"},{"key":"5838_CR27","first-page":"352","volume":"2","author":"ISKDC","year":"1972","unstructured":"ISKDC (1972) International workshop on risk benefit assessment of cyclophosphamide in renal disease. Kidney Int 2:352\u2013353","journal-title":"Kidney Int"},{"key":"5838_CR28","doi-asserted-by":"publisher","unstructured":"(1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 98:561\u2013564. https:\/\/doi.org\/10.1016\/s0022-3476(81)80760-3","DOI":"10.1016\/s0022-3476(81)80760-3"},{"key":"5838_CR29","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1007\/s00467-021-05135-3","volume":"36","author":"R Ehren","year":"2021","unstructured":"Ehren R, Benz MR, Brinkk\u00f6tter PT, D\u00f6tsch J, Eberl WR, Gellermann J, Hoyer PF, Jordans I, Kamrath C, Kemper MJ, Latta K, M\u00fcller D, Oh J, T\u00f6nshoff B, Weber S, Weber LT, German Society for Pediatric Nephrology (2021) Pediatric idiopathic steroid- sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline (S2e) - AWMF register no. 166\u2013001, 6\/2020. Pediatr Nephrol 36:2971\u20132985. https:\/\/doi.org\/10.1007\/s00467-021-05135-3","journal-title":"Pediatr Nephrol"},{"key":"5838_CR30","first-page":"67","volume":"103","author":"J Churg","year":"1979","unstructured":"Churg J, Duffy JL, Bernstein J (1979) Identification of dense deposit disease: a report for the International Study of Kidney Diseases in Children. Arch Pathol Lab Med 103:67\u201372","journal-title":"Arch Pathol Lab Med"},{"key":"5838_CR31","doi-asserted-by":"publisher","unstructured":"(1981) Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int 20:765\u2013771. https:\/\/doi.org\/10.1038\/ki.1981.209","DOI":"10.1038\/ki.1981.209"},{"key":"5838_CR32","doi-asserted-by":"publisher","unstructured":"(1984) Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years\u2019 observation. Report of the International Study of Kidney Disease in Children. Pediatrics 73:497\u2013501. https:\/\/doi.org\/10.1542\/peds.73.4.497","DOI":"10.1542\/peds.73.4.497"},{"key":"5838_CR33","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1681\/ASN.V85769","volume":"8","author":"P Tarshish","year":"1997","unstructured":"Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8:769\u2013776. https:\/\/doi.org\/10.1681\/ASN.V85769","journal-title":"J Am Soc Nephrol"},{"key":"5838_CR34","doi-asserted-by":"publisher","unstructured":"(1982) Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children. J Pediatr 101:514\u2013518. https:\/\/doi.org\/10.1016\/s0022-3476(82)80692-6","DOI":"10.1016\/s0022-3476(82)80692-6"},{"key":"5838_CR35","doi-asserted-by":"publisher","unstructured":"(1979) Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the International Study of Kidney Disease in Children. J Pediatr 95:239\u2013243. https:\/\/doi.org\/10.1016\/S0022-3476(79)80658-7","DOI":"10.1016\/S0022-3476(79)80658-7"},{"key":"5838_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00467-003-1315-x","volume":"19","author":"P Tarshish","year":"2004","unstructured":"Tarshish P, Bernstein J, Edelmann CM Jr (2004) Henoch-Sch\u00f6nlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatr Nephrol 19:51\u201356. https:\/\/doi.org\/10.1007\/s00467-003-1315-x","journal-title":"Pediatr Nephrol"},{"key":"5838_CR37","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/ki.2009.243","volume":"76","author":"DC Cattran","year":"2009","unstructured":"Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D\u2019Agati V, D\u2019Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534\u2013545. https:\/\/doi.org\/10.1038\/ki.2009.243","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"5838_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00467-006-0406-x","volume":"22","author":"G Arneil","year":"2007","unstructured":"Arneil G, Boda D, Ehrich JH, Fanconi A, Habib R, Hallman N (2007) The founding and early history of the European Society for Paediatric Nephrology (ESPN). Pediatr Nephrol 22(Suppl 1):1\u201315. https:\/\/doi.org\/10.1007\/s00467-006-0406-x","journal-title":"Pediatr Nephrol"},{"key":"5838_CR39","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1203\/00006450-200211000-00026","volume":"52","author":"RW Chesney","year":"2002","unstructured":"Chesney RW (2002) The development of pediatric nephrology. Pediatr Res 52:770\u2013778. https:\/\/doi.org\/10.1203\/00006450-200211000-00026","journal-title":"Pediatr Res"},{"key":"5838_CR40","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/s0272-6386(12)81040-7","volume":"16","author":"HL Barnett","year":"1990","unstructured":"Barnett HL, Edelmann CM Jr (1990) Development of pediatric nephrology. Am J Kidney Dis 16:557\u2013562. https:\/\/doi.org\/10.1016\/s0272-6386(12)81040-7","journal-title":"Am J Kidney Dis"},{"key":"5838_CR41","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/BF02093714","volume":"150","author":"J Brodehl","year":"1991","unstructured":"Brodehl J (1991) The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies. Eur J Pediatr 150:380\u2013387. https:\/\/doi.org\/10.1007\/BF02093714","journal-title":"Eur J Pediatr"},{"key":"5838_CR42","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ki.2014.260","volume":"87","author":"N Yoshikawa","year":"2015","unstructured":"Yoshikawa N, Nakanishi K, Sako M, Oba MS, Mori R, Ota E, Ishikura K, Hataya H, Honda M, Ito S, Shima Y, Kaito H, Nozu K, Nakamura H, Igarashi T, Ohashi Y, Iijima K (2015) Japanese Study Group of Kidney Disease in Children. A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment. Kidney Int 87:225\u2013232. https:\/\/doi.org\/10.1038\/ki.2014.260","journal-title":"Kidney Int"},{"key":"5838_CR43","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3389\/fped.2021.627636","volume":"9","author":"A Pasini","year":"2021","unstructured":"Pasini A, Bertulli C, Casadio L, Corrado C, Edefonti A, Ghiggeri G, Ghio L, Giordano M, La Scola C, Malaventura C, Maringhini S, Mastrangelo AP, Materassi M, Mencarelli F, Messina G, Monti E, Morello W, Puccio G, Romagnani P, Montini G, NefroKid Study Group (2021) Childhood idiopathic nephrotic syndrome: does the initial steroid treatment modify the outcome? A multicentre, prospective cohort study. Front Pediatr 9:627\u2013636. https:\/\/doi.org\/10.3389\/fped.2021.627636","journal-title":"Front Pediatr"},{"key":"5838_CR44","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/ki.2012.428","volume":"83","author":"CA Gadegbeku","year":"2013","unstructured":"Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PX, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ, Lienczewski CC, Adler SG, Appel GB, Cattran DC, Choi MJ, Contreras G, Dell KM, Fervenza FC, Gibson KL, Greenbaum LA, Hernandez JD, Hewitt SM, Hingorani SR, Hladunewich M, Hogan MC, Hogan SL, Kaskel FJ, Lieske JC, Meyers KE, Nachman PH, Nast CC, Neu AM, Reich HN, Sedor JR, Sethna CB, Trachtman H, Tuttle KR, Zhdanova O, Zilleruelo GE, Kretzler M (2013) Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int 83:749\u2013756. https:\/\/doi.org\/10.1038\/ki.2012.428","journal-title":"Kidney Int"},{"key":"5838_CR45","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/j.ajkd.2018.07.020","volume":"73","author":"LH Mariani","year":"2019","unstructured":"Mariani LH, Bomback AS, Canetta PA, Flessner MF, Helmuth M, Hladunewich MA, Hogan JJ, Kiryluk K, Nachman PH, Nast CC, Rheault MN, Rizk DV, Trachtman H, Wenderfer SE, Bowers C, Hill-Callahan P, Marasa M, Poulton CJ, Revell A, Vento S, Barisoni L, Cattran D, D\u2019Agati V, Jennette JC, Klein JB, Laurin LP, Twombley K, Falk RJ, Gharavi AG, Gillespie BW, Gipson DS, Greenbaum LA, Holzman LB, Kretzler M, Robinson B, Smoyer WE, Guay-Woodford LM, CureGN Consortium (2019) CureGN study rationale, design, and methods: establishing a large prospective observational study of glomerular disease. Am J Kidney Dis 73:218\u2013229. https:\/\/doi.org\/10.1053\/j.ajkd.2018.07.020","journal-title":"Am J Kidney Dis"},{"key":"5838_CR46","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2215\/CJN.06260614","volume":"10","author":"A Trautmann","year":"2015","unstructured":"Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M, Anarat A, Caliskan S, Emma F, Gellermann J, Oh J, Baskin E, Ksiazek J, Remuzzi G, Erdogan O, Akman S, Dusek J, Davitaia T, \u00d6zkaya O, Papachristou F, Firszt-Adamczyk A, Urasinski T, Testa S, Krmar RT, Hyla-Klekot L, Pasini A, \u00d6zcakar ZB, Sallay P, Cakar N, Galanti M, Terzic J, Aoun B, Caldas Afonso A, Szymanik-Grzelak H, Lipska BS, Schnaidt S, Schaefer F, PodoNet Consortium (2015) Spectrum of steroid- resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin J Am Soc Nephrol 10:592\u2013600. https:\/\/doi.org\/10.2215\/CJN.06260614","journal-title":"Clin J Am Soc Nephrol"},{"key":"5838_CR47","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00467-020-04519-1","volume":"35","author":"A Trautmann","year":"2020","unstructured":"Trautmann A, Vivarelli M, Samuel S, Gipson D, Sinha A, Schaefer F, Hui NK, Boyer O, Saleem MA, Feltran L, M\u00fcller-Deile J, Becker JU, Cano F, Xu H, Lim YN, Smoyer W, Anochie I, Nakanishi K, Hodson E, Haffner D, International Pediatric Nephrology Association (2020) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 35:1529\u20131561. https:\/\/doi.org\/10.1007\/s00467-020-04519-1","journal-title":"Pediatr Nephrol"},{"key":"5838_CR48","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s13312-021-2217-3","volume":"58","author":"A Sinha","year":"2021","unstructured":"Sinha A, Bagga A, Banerjee S, Mishra K, Mehta A, Agarwal I, Uthup S, Saha A, Mishra OP, Expert Group of Indian Society of Pediatric Nephrology (2021) Steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr 58:650\u2013666. https:\/\/doi.org\/10.1007\/s13312-021-2217-3","journal-title":"Indian Pediatr"},{"key":"5838_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-022-05739-3","author":"A Trautmann","year":"2022","unstructured":"Trautmann A, Boyer O, Hodson E, Bagga A, Gipson DS, Samuel S, Wetzels J, Alhasan K, Banerjee S, Bhimma R, Bonilla-Felix M, Cano F, Christian M, Hahn D, Kang HG, Nakanishi K, Safouh H, Trachtman H, Xu H, Cook W, Vivarelli M, Haffner D, International Pediatric Nephrology Association (2022) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-022-05739-3","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"5838_CR50","doi-asserted-by":"publisher","first-page":"CD002290","DOI":"10.1002\/14651858","volume":"16","author":"NG Larkins","year":"2020","unstructured":"Larkins NG, Liu ID, Willis NS, Craig JC, Hodson EM (2020) Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. Cochrane Database Syst Rev 16(4):CD002290. https:\/\/doi.org\/10.1002\/14651858","journal-title":"Cochrane Database Syst Rev"},{"key":"5838_CR51","doi-asserted-by":"publisher","first-page":"CD001533","DOI":"10.1002\/14651858","volume":"31","author":"D Hahn","year":"2020","unstructured":"Hahn D, Samuel SM, Willis NS, Craig JC, Hobson EM (2020) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 31:CD001533. https:\/\/doi.org\/10.1002\/14651858","journal-title":"Cochrane Database Syst Rev"},{"key":"5838_CR52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00467-021-04985-1","volume":"37","author":"MT Christian","year":"2022","unstructured":"Christian MT, Maxted AP (2022) Optimizing the corticosteroid dose in steroid- sensitive nephrotic syndrome. Pediatr Nephrol 37:37\u201347. https:\/\/doi.org\/10.1007\/s00467-021-04985-1","journal-title":"Pediatr Nephrol"},{"key":"5838_CR53","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1053\/j.ajkd.2022.05.005","volume":"80","author":"E Hodson","year":"2022","unstructured":"Hodson E, Hahn D, Craig J (2022) Prednisone for steroid-sensitive nephrotic syndrome. Can we use lower doses for the first presentation in children. Am J Kidney Dis 80:433\u2013435. https:\/\/doi.org\/10.1053\/j.ajkd.2022.05.005","journal-title":"Am J Kidney Dis"},{"key":"5838_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00467-022-05520-6","volume":"28","author":"AM McKay","year":"2022","unstructured":"McKay AM, Parekh RS, Noone D (2022) Therapeutic trials in difficult to treat steroid sensitive nephrotic syndrome: challenges and future directions. Pediatr Nephrol 28:1\u201318. https:\/\/doi.org\/10.1007\/s00467-022-05520-6","journal-title":"Pediatr Nephrol"},{"key":"5838_CR55","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s00467-021-05401-4","volume":"37","author":"T Horinouchi","year":"2022","unstructured":"Horinouchi T, Nozu K, Iijima K (2022) An updated view of the pathogenesis of steroid-sensitive nephrotic syndrome. Pediatr Nephrol 37:1957\u20131965. https:\/\/doi.org\/10.1007\/s00467-021-05401-4","journal-title":"Pediatr Nephrol"},{"key":"5838_CR56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0065-3101(22)00823-4","volume":"5","author":"HL Barnett","year":"1952","unstructured":"Barnett HL, Forman CW, Lauson HD (1952) The nephrotic syndrome in children. Adv Pediatr 5:53\u2013128","journal-title":"Adv Pediatr"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05838-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-022-05838-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05838-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T12:02:46Z","timestamp":1697630566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-022-05838-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["5838"],"URL":"https:\/\/doi.org\/10.1007\/s00467-022-05838-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"assertion":[{"value":"26 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kevin Lemley is an Associate Editor of Pediatric Nephrology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}